Epoprostenol use for pulmonary arterial hypertension in the palliative care setting

Colin P. Wozencraft, Patrick J. Coyne, Daniel C. Grinnan, Thomas D. Morel, Katie M. Muzevich, Thomas J. Smith

Research output: Contribution to journalReview articlepeer-review

Abstract

Prostacyclin analogues such as epoprostenol (Flolan®) are commonly used in the treatment of pulmonary arterial hypertension (PAH). However, their complex administration and significant cost may limit the access that patients with PAH have to palliative and hospice care. We herein report our experience using epoprostenol in a dedicated palliative care unit and present our inpatient protocol for the drug's administration.

Original languageEnglish (US)
Pages (from-to)619-622
Number of pages4
JournalJournal of palliative medicine
Volume15
Issue number5
DOIs
StatePublished - May 1 2012

ASJC Scopus subject areas

  • Nursing(all)
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Epoprostenol use for pulmonary arterial hypertension in the palliative care setting'. Together they form a unique fingerprint.

Cite this